Suma Krishnan, President, R&D at Krystal Biotech, Inc. (KRYS), sold 49,559 shares at $81.41 ($4.0M) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $4.0M KRYS by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.70 | 20,617 | $1.7M | 41.5% |
| 2 | $80.70 | 20,617 | $1.7M | 41.5% |
| 3 | $81.41 | 1,186 | $97K | 2.4% |
| 4 | $81.41 | 1,186 | $97K | 2.4% |
| 5 | $82.71 | 346 | $29K | 0.7% |
| 6 | $82.72 | 345 |
| $29K |
| 0.7% |
| 7 | $80.75 | 2,048 | $165K | 4.1% |
| 8 | $81.56 | 803 | $65K | 1.6% |
| 9 | $81.56 | 803 | $65K | 1.6% |
| 10 | $81.56 | 804 | $66K | 1.6% |
| 11 | $81.56 | 804 | $66K | 1.6% |
| Total | $80.82 avg | 49,559 | $4.0M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |